In vitro expansion of human and mouse mast cells by the ligand for c-ki
In vitro expansion of human and mouse mast cells by the ligand for c-ki
批准号:
03454262
负责人:
NAKAHATA Tatsutoshi
金额:
$3.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
肥大细胞来源于多能造血干细胞,并分为至少两个表型不同的亚群;结缔组织型肥大细胞(CTMC)和粘膜肥大细胞(MMC)。当用IL-3培养正常小鼠骨髓细胞时,产生大量肥大细胞,相当于MMC亚类的组织培养物。从小鼠腹膜呼叫中纯化的成熟CTMC可以在IL-3和IL-4存在下增殖。干细胞因子(SCF)是c-kit酪氨酸激酶受体的配体,被证明与多种细胞因子(包括IL-3、IL-6和G-CSF)协同作用于早期造血祖细胞的发育。虽然SCF单独不能从骨髓谱系阴性细胞中诱导肥大细胞,但它与IL-3联合可刺激肥大细胞的产生。SCF、IL-3均不能诱导纯化成熟CTMC的肥大细胞集落,但SCF与IL-3、IL-4或GM-CSF在体外对小鼠CTMC的增殖有显著的协同作用。抗c-kit受体抗体(ACK2)能完全阻断SCF的活性,但不能阻断IL-3对CTMC生长的影响。当我们在SCF存在下培养从脐带血或骨髓细胞中纯化的人CD34^+细胞时,在培养14天后首次检测到人肥大细胞,并在培养50天后急剧增加。脐带血CD34^+细胞培养60天后,SCF、SCF+IL-6或SCF+IL-11培养的细胞90%以上为肥大细胞。IL-3和GM-CSF显著抑制scf依赖性肥大细胞的增殖。
英文摘要
Mast cell are derived from multipotential hematopoietic stem cells and classified into at least two phenotypically distinct subpopulations; connective tissue-type mast cells (CTMC) and mucosal mast cells (MMC). When normal mouse bone marrow cells were cultured with IL-3, a large number of mast cells ,which were tissue culture equivalents of the MMC subclass, were developed. Mature CTMC purified from mouse peritoneal calls could proliferate in the presence of both IL-3 and IL-4. Stem cell factor (SCF), the ligand for the c-kit tyrosine kinase receptor, demonstrated to act synergistically with a variety of cytokines including IL-3, IL-6, and G-CSF on the development of early hematopoietic progenitors. Although SCF alone failed to induce mast cells from bone marrow lineage negative cells, it stimulated mast cell production in combination with IL-3. Either SCF, IL-3 alone could not induce mast cell colonies from purified mature CTMC, but SCF revealed significant cooperative actions with IL-3, IL-4 or GM-CSF on the proliferation of mouse CTMC in vitro. The anti-c-kit receptor antibody (ACK2) completely blocked the activity of SCF but not of IL-3 on the growth of CTMC. When we cultured human CD34^+ cells purified from cord blood or bone marrow cells in the presence of SCF, human mast cells first detected on 14 days of incubation and increased dramatically after 50 days of culture. More than 90% of the cells in culture with SCF,SCF+IL-6 or SCF+IL-11 were mast cells after 60 days of culture of cord blood CD34^+ cells. IL-3 and GM-CSF significantly inhibited SCF-dependent mast cell proliferation.
期刊论文(160)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Seki T.,Nakahata T.,et al.: "A case of cell mediated immune-pancytopenia complicating primary Sjogren's syndrome." Am.J.Hematol.
Seki T.,Nakahata T.,et al.:“细胞介导的免疫全血细胞减少症并发原发性干燥综合征的病例。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Siohara M., Koike K., Nakahata T.: "Synergism of interferon-gamma and stem cell factor on development of murine hematopoietic progenitors in serum-free culture." Blood.
Siohara M.、Koike K.、Nakahata T.:“干扰素-γ 和干细胞因子对无血清培养中小鼠造血祖细胞发育的协同作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sawayanagi M .,Nakahata T.,ed al.: "Hypercalcemia associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemia." Leukemia Res.
Sawayanagi M .、Nakahata T. 等人:“治疗急性早幼粒细胞白血病时与全反式视黄酸相关的高钙血症。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakazawa T., Nakahata T.,ed al.: "Beneficial effect of G-CSF in an infant with Pasteurella Multocida brain abscess." Eur.J.Pediatr.
Nakazawa T.、Nakahata T.等人:“G-CSF 对患有多杀性巴氏杆菌脑脓肿的婴儿的有益作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakahata T.,ed al.: "Cell surface antigen expressions human erythroid progenitors:erythroid and megakaryocytic markers." Leukemia and Lymphoma.
Nakahata T.,ed al.:“细胞表面抗原表达人类红细胞祖细胞:红细胞和巨核细胞标记。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 69 条
Hematopoietic stem cell potential is propagated by human pluripotent stem cell-derived endothelial stroma
-
批准号:24659496
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Recapitulation of phenotypes and discovery of a novel treatment with disease-specific human ES/ iPS cells from various hereditary diseases
-
批准号:22249042
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.87万
-
财政年份:2010
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Analysis of proliferation and differentiation of human embryonic stem cells and research for clinical application
-
批准号:19109006
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$69.89万
-
财政年份:2007
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
molecular cloning of self-renewal factor for hematopoietic stem cells and its clinical application
-
批准号:11357008
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$22.4万
-
财政年份:1999
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Studies of differentiation mechanisms of hematopoietic stem cells using cytokine-receptor transgenic mice
-
批准号:10307020
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$24.83万
-
财政年份:1998
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Production of erythrocytes, granulocytes and megakaryocytes by gp130 signalling and related molecular mechanisms.
-
批准号:07407023
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$16.96万
-
财政年份:1995
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Cytokine productions from murine and human mast cells
-
批准号:05454285
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.33万
-
财政年份:1993
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Effects of Interleukins and Hemopoietic Growth Factors on Proliferation of Multipotent Stem Cell and Leukemic Cells.
-
批准号:01480258
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.48万
-
财政年份:1989
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
Effects of IL-3 and IL-4 on proliferation and transdifferentiation of mast cells
-
批准号:62570419
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1987
-
负责人:NAKAHATA Tatsutoshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于氧化应激介导的SCF/c-kit系统探讨靶向菌群调控ASD情绪及社交行为障碍的机制研究
-
批准号:JCZRLH202600725
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
铁过载介导SCF-FBXL4泛素E3连接酶复合物-BNIP3/NIX线粒体自噬通路促进眼表炎症参与干眼发病机制
-
批准号:2026JJ81109
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏世刚
-
依托单位:
ZC3H13以m6A依赖性方式稳定LINC00504表达促进SCFβ-TRCP介导CPEB1泛素化降解调控酒精相关食管癌增长、转移、糖代谢和M2巨噬细胞极化的机制研究
-
批准号:2025JJ81096
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:倪志超
-
依托单位:
八味解郁汤通过调控SCF/c-kit/Akt信号通路对功能性消化不良大鼠氧化应激损伤及肠胃动力的影响
-
批准号:2025JJ80922
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:邹君君
-
依托单位:
干细胞因子SCF在心脏发育和修复中的作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:张璐
-
依托单位:
miR-221-3p 靶向 c-kit 介导 SCF/c-kit 调控 ICC 自噬影响肠动力机制及枳术丸干预研究
-
批准号:2024JJ7358
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:夏旭婷
-
依托单位:
基于“肝-肠-菌”轴探讨大黄灵仙方调控SCF/c-kit通路拮抗胆管炎的机制研究
-
批准号:82360889
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:俞渊
-
依托单位:
PRMT1调控SCF复合物组装参与肝再生的机制研究
-
批准号:82370639
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:孙青竹
-
依托单位:
FSH调控SCF/C-kit通路介导头颅照射致生精障碍远端效应的机制研究
-
批准号:82304068
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:郭玲
-
依托单位:
基于泛素化连接酶复合物SCF(TBL1)介导Wnt/β-catenin信号通路探讨莪术抑制上皮-间质转化防治子宫内膜异位症的机制
-
批准号:82305010
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:童黄锦
-
依托单位: